SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ACADIA Pharmaceuticals Inc (ACAD)
ACAD 25.44+2.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (188)10/18/2005 12:42:44 PM
From: scaram(o)uche   of 588
 
Item 5. Ownership of Five Percent or Less of a Class

Reporting persons are holding 1.29% (0% in the case of
OrbiMed Advisors LLC and 1.29% in the case of OrbiMed Capital LLC) of
the securities on behalf of other persons who have the right to
receive or the power to direct the receipt of dividends from, or
proceeds from sale of, such securities. No one such other person's
interest in the securities whose ownership is reported here relates
to more than five percent of the class.

OrbiMed Capital LLC hold shares on behalf of Finsbury Worldwide
Pharmaceutical Trust (302,600 shares).


excerpts from the recent S-3A......

Orbimed Advisors LLC affiliates(5)
1,395,612 6.0

(snip)

(5) Includes 621,606 shares (including 359,603 shares being offered by this prospectus) owned by Eaton Vance Worldwide Health Sciences Fund and 774,006 shares owned by Finsbury Worldwide Pharmaceutical Trust. OrbiMed Advisors LLC provides investment advisory services to Eaton Vance Worldwide Health Sciences Fund and Finsbury Worldwide Pharmaceutical Trust, and holds voting and investment power over the shares held by those funds. The address of OrbiMed Advisors LLC is 767 Third Avenue, 30th Floor, New York, New York 10017-2023.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext